Sponsor-Vendor Responsibilities

Sponsor-vendor responsibilities are important in clinical research because sponsors frequently use external service providers to perform trial-related activities. These service providers may include contract research organisations (CROs), laboratories, data-management providers, technology providers, central imaging services and other specialised vendors.

Although trial-related activities may be transferred to or performed by service providers, responsibilities should be clearly defined and documented, and the sponsor should maintain appropriate oversight of activities performed on its behalf.

Sponsor Responsibilities

The sponsor is responsible for establishing appropriate arrangements for the design, management and oversight of the clinical trial.

Sponsor responsibilities may include:

• Establishing the clinical trial design and protocol
• Selecting qualified investigators and service providers
• Providing appropriate trial information and resources
• Implementing quality-management processes
• Overseeing trial conduct and participant safety
• Managing investigational products where applicable
• Ensuring appropriate data management and statistical processes
• Evaluating safety information
• Monitoring trial activities
• Maintaining required sponsor records
• Meeting applicable regulatory reporting requirements

The sponsor should ensure that trial-related activities are conducted in accordance with the protocol, Good Clinical Practice and applicable regulatory requirements.

Use of Vendors and Service Providers

Sponsors may use vendors or other service providers to perform a wide range of trial-related activities.

Depending on the trial, these activities may include monitoring, data management, statistical programming, laboratory services, investigational product logistics, electronic systems, imaging, safety services or other specialised functions.

The activities performed by a service provider and the responsibilities of the parties should be appropriately documented.

Sponsor Responsibility and Oversight

Using a service provider does not eliminate the sponsor’s responsibility for sponsor activities.

The sponsor should maintain appropriate oversight of activities performed on its behalf. The nature and extent of oversight should be proportionate to the importance and risks associated with the transferred activities.

Oversight may involve review of performance information, quality indicators, significant issues, deviations, corrective actions and other information relevant to the reliability and quality of the service being provided.

Current expectations for sponsor oversight and service providers are addressed in the ICH E6 Good Clinical Practice guideline.

Selection of Service Providers

The sponsor should assess whether a prospective service provider is suitable to perform the activities assigned to it.

The assessment should be proportionate to the significance and risks of the activities being performed and may consider:

• Relevant experience and expertise
• Qualified personnel and resources
• Quality-management processes
• Technology and computerized systems
• Regulatory and GCP experience
• Operational capabilities
• Previous performance
• Ability to meet trial-specific requirements

The level of evaluation should reflect the nature and importance of the service.

Documenting Responsibilities

Responsibilities transferred to or performed by a vendor should be clearly documented.

Contracts, agreements, plans or other appropriate documentation may describe:

• Activities and deliverables
• Roles and responsibilities
• Communication and escalation processes
• Quality expectations
• Access to relevant records and systems
• Safety-reporting responsibilities
• Data ownership and handling
• Confidentiality requirements
• Timelines and performance expectations

Clear documentation reduces uncertainty and helps the sponsor and vendor understand their respective obligations.

Vendor Responsibilities

A vendor should perform assigned trial-related activities in accordance with the applicable agreement, protocol, procedures, Good Clinical Practice and regulatory requirements relevant to those activities.

Vendor responsibilities may include:

• Maintaining appropriately qualified personnel
• Performing assigned activities according to agreed requirements
• Maintaining appropriate records
• Protecting confidential trial information
• Maintaining suitable quality controls
• Reporting significant issues to the sponsor
• Supporting sponsor oversight
• Providing access to relevant records and information when required

The exact responsibilities of a vendor depend on the services it has been engaged to perform.

Further Subcontracting

A service provider may sometimes use another service provider to perform part of an assigned activity.

Arrangements for further subcontracting should be appropriately controlled and should not reduce the sponsor’s ability to oversee important trial activities.

The sponsor should have appropriate visibility of subcontracted activities when they could affect participant protection or the reliability of trial results.

Responsibilities, communication pathways and access to relevant information should remain sufficiently clear throughout the service-provider chain.

Communication and Escalation

Effective communication between the sponsor and vendor is essential throughout the clinical trial.

Communication arrangements should define how important information, operational issues, safety matters, quality concerns and significant deviations are communicated and escalated.

Critical issues should be communicated promptly enough to allow appropriate evaluation and action.

Vendor Performance and Quality Issues

Vendor performance should be evaluated throughout the period in which the service provider performs trial-related activities.

The sponsor should identify and address significant performance or quality issues that could affect participant safety, trial conduct or the reliability of trial results.

Where appropriate, corrective and preventive actions should be implemented and followed through to resolution.

For more information on ongoing oversight after a provider has been selected, see Clinical Research Vendor Management.

Access to Records and Information

The sponsor should have appropriate access to information necessary to oversee activities performed by service providers.

Relevant records should also be available for authorised monitoring, audit or regulatory inspection when required.

Agreements with service providers should therefore support appropriate access, retention and availability of important trial information.

Importance of Sponsor-Vendor Responsibilities

Clear sponsor-vendor responsibilities support effective trial management, participant protection and reliable clinical trial results.

External service providers can provide valuable expertise and operational capabilities, but outsourcing does not remove the need for appropriate sponsor oversight.

Clearly documented responsibilities, proportionate vendor qualification, effective communication and ongoing oversight help ensure that outsourced clinical trial activities are performed appropriately and remain integrated within the trial’s overall quality-management framework.

You may be interested in the programs below: